Kymriah

Ended Awarded Last action

Contract number
36C24219F0479
Awardee
Awarding agency
Obligated
$283,568

Award facts

Contract value 100% obligated
$283,567.92 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
East Hanover, NJ 07936, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00001 · Kymriah administrative modification to allow distributor to invoice/bill per the vendor's FSS contract. $0
Original award $283,568

About this award

The Department of Veterans Affairs Veterans Health Administration awarded a $283,567.92 delivery order to Novartis Pharmaceuticals Corporation (doing business as NPS), a foreign-owned for-profit manufacturer of pharmaceuticals and drugs. The order was placed against Novartis' Federal Supply Schedule 61-IB contract for pharmaceuticals and drugs, which has a total potential value of $5.4 billion and runs through August 2025. The delivery order was for Novartis' Kymriah, a chimeric antigen receptor T-cell therapy, to support medical treatment for veterans. The order was placed on a firm fixed price basis with no set-aside designation. Novartis has provided over $2.8 million in Kymriah orders to various VHA networks and facilities, and the VA also awarded Novartis a $21.5 million blanket purchase agreement against the pharmaceutical schedule to continue Kymriah orders through September 2024.

Quick answers

Who was awarded contract 36C24219F0479?

36C24219F0479 was awarded to Novartis Pharmaceuticals Corporation by Veterans Integrated Service Network 2 (Veterans Health Administration) on July 31, 2019.

How much is contract 36C24219F0479 worth?

The government has obligated $283,568 on 36C24219F0479.

Is contract 36C24219F0479 an order under another contract?

Yes. 36C24219F0479 is a delivery order under V797D30268, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C24219F0479 competed?

The extent of competition for 36C24219F0479 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award